<bill session="116" type="s" number="4648" updated="2023-01-11T13:44:44Z">
  <state datetime="2020-09-22">REFERRED</state>
  <status>
    <introduced datetime="2020-09-22"/>
  </status>
  <introduced datetime="2020-09-22"/>
  <titles>
    <title type="display">A bill to amend the Controlled Substances Act to list isotonitazene as a schedule I controlled substance.</title>
    <title type="official" as="introduced">A bill to amend the Controlled Substances Act to list isotonitazene as a schedule I controlled substance.</title>
  </titles>
  <sponsor bioguide_id="C001095"/>
  <cosponsors/>
  <actions>
    <action datetime="2020-09-22">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2020-09-22" state="REFERRED">
      <text>Read twice and referred to the Committee on the Judiciary.</text>
      <reference ref="CR S5790-5791" label="Sponsor introductory remarks on measure"/>
    </action>
  </actions>
  <committees>
    <committee code="SSJU" name="Senate Judiciary" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Crime and law enforcement"/>
    <term name="Drug trafficking and controlled substances"/>
  </subjects>
  <amendments/>
  <summary date="2020-11-19T21:34:41Z" status="Introduced in Senate">This bill adds certain synthetic opioids to schedule I of the Controlled Substances Act. (A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.)</summary>
</bill>
